The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Efficacy of Morphine in Humans with Chronic Benign Pain
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 87 (5) , 1117-1120
- https://doi.org/10.1213/00000539-199811000-00025
Abstract
The effect of proglumide, a nonspecific CCK agonist, on analgesia in patients taking morphine on a chronic basis. Forty patients with intractable pain who were taking sustained-release morphine were recruited, and we obtained results from 36 of these patients. Median visual analog scale scores before the study were 8 and 7 after the addition of placebo for 2 wk (P = 0.16), and 6 after proglumide for 2 wk (P = 0.002). Mobility was unchanged by proglumide or placebo. Of the 36 patients, 13 elected to continue receiving proglumide after the study. We conclude that proglumide enhances the analgesia produced by morphine in some, but not all, patients with chronic benign pain. Implications: The pain-killing effect of morphine is incomplete in some patients. Increasing doses may be needed to maintain the initial effect. The peptide cholecystokinin may be partially responsible for this. In this study, we demonstrated that the cholecystokinin antagonist proglumide increases the analgesic effect of morphine in some patients with chronic benign pain. (Anesth Analg 1998;87:1117-20)...This publication has 22 references indexed in Scilit:
- Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the ratPublished by Elsevier ,2003
- Opioid and anti‐opioid peptidesFundamental & Clinical Pharmacology, 1995
- CCK antagonists: Pharmacology and therapeutic interestPharmacology & Therapeutics, 1994
- Differential modulation of α2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological studyBrain Research, 1994
- Chronic pain-related behaviors in spinally injured rats: Evidence for functional alterations of the endogenous cholecystokinin and opioid systemsPain, 1994
- Biological actions of cholecystokininPeptides, 1994
- The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistryBrain Research, 1994
- Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of painBritish Journal of Pharmacology, 1993
- Release of cholecystokinin in the central nervous systemNeurochemistry International, 1993
- Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammationBritish Journal of Pharmacology, 1993